Previous 10 | Next 10 |
home / stock / tgtx / tgtx articles
Shares of Aehr Test Systems (NASDAQ: AEHR) shares fell sharply in pre-market trading after the company lowered its full-year revenue guidance. The...
Preliminary U.S. BRIUMVI fourth quarter and full year 2023 net product revenue of approximately $40 million and $89 million, respectively Prelimin...
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 60 points on Wednesday. Shares of PriceSmart, Inc. (NASDAQ: PS...
Precision BioSciences, Inc. (NASDAQ: DTIL) shares are trading higher Tuesday after the company announced it has signed a licensing agreement with T...
TG Therapeutics, Inc. (NASDAQ: TGTX) shares are trading lower Tuesday, though the stock remains up 18% over the past five days. Here's a look a...
The Nasdaq 100 closed higher by over 2% on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it coul...
NEW YORK, Jan. 05, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX), today announced that Michael S. Weiss, the Company's Chair...
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results. AeroVironment posted ad...
U.S. stocks traded higher, with the Dow Jones index gaining more than 50 points on Wednesday. Shares of THOR Industries, Inc. (NYSE: THO) shares mo...
News, Short Squeeze, Breakout and More Instantly...
2024-07-04 22:48:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-25 00:38:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Goldman Sachs 45 th Annual Global Healthcare Conference, being held at the Loews Miami Bea...